Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProTrans in Severe COVID-19 Pneumonia
NCT04869397Phase 2Terminated
- Sponsor
- McGill University Health Centre
- Start
- Jun 2021
- Primary completion
- May 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ProTrans in COVID-19 pneumonia, sponsored by McGill University Health Centre. Started Jun 2021; status: terminated.
02
Drugs
ProTrans
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04869397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04869397.